Publika - Scientific publications from Oslo University Hospital

RSS feed RSS

Publications (original articles or review articles) published in 2013 from OUS - Department of Cardiology B (Div Med)

72 publications found

Agewall S (2013)
[New European guidelines for acute and chronic heart failure]
Lakartidningen, 110 (13-14), 672-3
PubMed 23634620

Agewall S, Cattaneo M, Collet JP, Andreotti F, Lip GY, Verheugt FW, Huber K, Grove EL, Morais J, Husted S, Wassmann S, Rosano G, Atar D, Pathak A, Kjeldsen K, Storey RF, ESC Working Group on Cardiovascular Pharmacology and Drug Therapy and ESC Working Group on Thrombosis (2013)
Expert position paper on the use of proton pump inhibitors in patients with cardiovascular disease and antithrombotic therapy
Eur Heart J, 34 (23), 1708-13, 1713a-1713b
DOI 10.1093/eurheartj/eht042, PubMed 23425521

Alexander JH, Lopes RD, Thomas L, Alings M, Atar D, Aylward P, Goto S, Hanna M, Huber K, Husted S, Lewis BS, McMurray JJ, Pais P, Pouleur H, Steg PG, Verheugt FW, Wojdyla DM, Granger CB, Wallentin L (2013)
Apixaban vs. warfarin with concomitant aspirin in patients with atrial fibrillation: insights from the ARISTOTLE trial
Eur Heart J, 35 (4), 224-32
DOI 10.1093/eurheartj/eht445, PubMed 24144788

Armstrong PW, Gershlick AH, Goldstein P, Wilcox R, Danays T, Lambert Y, Sulimov V, Rosell Ortiz F, Ostojic M, Welsh RC, Carvalho AC, Nanas J, Arntz HR, Halvorsen S, Huber K, Grajek S, Fresco C, Bluhmki E, Regelin A, Vandenberghe K, Bogaerts K, Van de Werf F, STREAM Investigative Team (2013)
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction
N Engl J Med, 368 (15), 1379-87
DOI 10.1056/NEJMoa1301092, PubMed 23473396

Bang CN, Dalsgaard M, Greve AM, Køber L, Gohlke-Baerwolf C, Ray S, Rossebø AB, Egstrup K, Wachtell K (2013)
Left atrial size and function as predictors of new-onset of atrial fibrillation in patients with asymptomatic aortic stenosis: the simvastatin and ezetimibe in aortic stenosis study
Int J Cardiol, 168 (3), 2322-7
DOI 10.1016/j.ijcard.2013.01.060, PubMed 23416018

Berge T, Ulimoen SR, Enger S, Arnesen H, Seljeflot I, Tveit A (2013)
Impact of atrial fibrillation on inflammatory and fibrinolytic variables in the elderly
Scand J Clin Lab Invest, 73 (4), 326-33
DOI 10.3109/00365513.2013.780093, PubMed 23586783

Bruins Slot KM, Berge E (2013)
Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Cochrane Database Syst Rev (8), CD008980
DOI 10.1002/14651858.CD008980.pub2, PubMed 23925867

Catalano M, Poredos P, Brodmann M, Wautrecht JC, Carpentier P, Roztocil K, Nikol S, Diamantopoulos E, Pecsvarady Z, Carlizza A, Sieron A, Stanek A, Olinic D, Stvrtinova V, Kozak M, Agewall S, Gallino A, Jaeger KA, Fitzgerald P, Colgan MP (2013)
Requirements for angiology/vascular medicine
Int Angiol, 32 (6), 608-12
PubMed 24212296

Crisby M, Henareh L, Agewall S (2013)
Relationship between oxidized LDL, IgM, and IgG autoantibodies to ox-LDL levels with recurrent cardiovascular events in Swedish patients with previous myocardial infarction
Angiology, 65 (10), 932-6
DOI 10.1177/0003319713512720, PubMed 24288363

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI (2013)
Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease
Thromb Haemost, 110 (6), 1087-107
DOI 10.1160/TH13-06-0443, PubMed 24226379

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI, European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease (2013)
General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease
Thromb Haemost, 109 (4), 569-79
DOI 10.1160/TH12-10-0772, PubMed 23447024

De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Verheugt FW, Weitz JI, European Society of Cardiology Working Group on Thrombosis Task Force on Anticoagulants in Heart Disease (2013)
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease
Thromb Haemost, 109 (5), 769-86
DOI 10.1160/TH12-06-0403, PubMed 23636477

Fadl Elmula FE, Hoffmann P, Fossum E, Brekke M, Gjønnæss E, Hjørnholm U, Kjær VN, Rostrup M, Kjeldsen SE, Os I, Stenehjem AE, Høieggen A (2013)
Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure
Hypertension, 62 (3), 526-32
DOI 10.1161/HYPERTENSIONAHA.113.01452, PubMed 23836798

Frankenstein L, Katus HA, Grundtvig M, Hole T, de Blois J, Schellberg D, Atar D, Zugck C, Agewall S, Norwegian Heart Failure Registry steering committee (2013)
Association between spironolactone added to beta-blockers and ACE inhibition and survival in heart failure patients with reduced ejection fraction: a propensity score-matched cohort study
Eur J Clin Pharmacol, 69 (10), 1747-55
DOI 10.1007/s00228-013-1512-x, PubMed 23743778

Ghanavatian S, Diep LM, Bárány P, Heimbürger O, Seeberger A, Stenvinkel P, Rohani M, Agewall S (2013)
Subclinical atherosclerosis, endothelial function, and serum inflammatory markers in chronic kidney disease stages 3 to 4
Angiology, 65 (5), 443-9
DOI 10.1177/0003319713483000, PubMed 23567479

Ghanima W, Atar D, Sandset PM (2013)
New oral anticoagulants--a review
Tidsskr Nor Laegeforen, 133 (18), 1940-5
DOI 10.4045/tidsskr.12.1111, PubMed 24084970

Grundvold I, Skretteberg PT, Liestøl K, Erikssen G, Engeseth K, Gjesdal K, Kjeldsen SE, Arnesen H, Erikssen J, Bodegard J (2013)
Low heart rates predict incident atrial fibrillation in healthy middle-aged men
Circ Arrhythm Electrophysiol, 6 (4), 726-31
DOI 10.1161/CIRCEP.113.000267, PubMed 23873309

Gulati G, Heck SL, Ree AH, Gravdehaug B, Røsjø H, Steine K, Bratland Å, Hoffmann P, Geisler J, Omland T (2013)
[Cardioprotective treatment during adjuvant cancer therapy]
Tidsskr Nor Laegeforen, 133 (17), 1832-6
DOI 10.4045/tidsskr.12.1514, PubMed 24042297

Hall TS, Herrscher T, Jarolim P, Fagerland MW, Jensen T, Hallén J, Agewall S, Atar D (2013)
Obstructive sleep apnea: no independent association to troponins
Sleep Breath, 18 (2), 351-8
DOI 10.1007/s11325-013-0892-6, PubMed 24043484

Halvorsen S, Huber K (2013)
Fibrinolytic treatment of ST-elevation myocardial infarction. Update 2014
Hamostaseologie, 34 (1), 47-53
DOI 10.5482/HAMO-13-07-0040, PubMed 24085113

Hijazi Z, Siegbahn A, Andersson U, Granger CB, Alexander JH, Atar D, Gersh BJ, Mohan P, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L, ARISTOTLE Investigators (2013)
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
Circulation, 129 (6), 625-34
DOI 10.1161/CIRCULATIONAHA.113.006286, PubMed 24226808

Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Granger CB, ARISTOTLE Investigators (2013)
High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin
J Am Coll Cardiol, 63 (1), 52-61
DOI 10.1016/j.jacc.2013.07.093, PubMed 24055845

Hjeltnes G, Hollan I, Førre O, Wiik A, Lyberg T, Mikkelsen K, Agewall S (2013)
Serum levels of lipoprotein(a) and E-selectin are reduced in rheumatoid arthritis patients treated with methotrexate or methotrexate in combination with TNF-α-inhibitor
Clin Exp Rheumatol, 31 (3), 415-21
PubMed 23465067

Hopp E, Bjørnerud A, Lunde K, Solheim S, Aakhus S, Arnesen H, Forfang K, Edvardsen T, Smith HJ (2013)
Perfusion MRI at rest in subacute and chronic myocardial infarct
Acta Radiol, 54 (4), 401-11
DOI 10.1177/0284185113475605, PubMed 23401603

Hornslien AG, Sandset EC, Bath PM, Wyller TB, Berge E, Scandinavian Candesartan Acute Stroke Trial Study Group (2013)
Effects of candesartan in acute stroke on cognitive function and quality of life: results from the Scandinavian Candesartan Acute Stroke Trial
Stroke, 44 (7), 2022-4
DOI 10.1161/STROKEAHA.113.001022, PubMed 23660849

Husebye T, Eritsland J, Müller C, Sandvik L, Arnesen H, Seljeflot I, Mangschau A, Bjørnerheim R, Andersen GØ (2013)
Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study
Eur J Heart Fail, 15 (5), 565-72
DOI 10.1093/eurjhf/hfs215, PubMed 23288914

Jander N, Gohlke-Bärwolf C, Bahlmann E, Gerdts E, Boman K, Chambers JB, Egstrup K, Nienaber CA, Pedersen TR, Ray S, Rossebø AB, Willenheimer R, Kienzle RP, Wachtell K, Neumann FJ, Minners J (2013)
Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis
Heart, 100 (1), 28-33
DOI 10.1136/heartjnl-2013-304443, PubMed 23969478

Jogestrand T, Agewall S, Gustafsson T, Henareh L (2013)
Conventional treatment after myocardial infarction in routine clinical practice results in regression of left common carotid intima-media thickness
Clin Physiol Funct Imaging, 34 (4), 322-6
DOI 10.1111/cpf.12101, PubMed 24237780

Johnson J, Manouras A, Bergholm F, Brodin LÅ, Agewall S, Henareh L (2013)
The early diastolic myocardial velocity: a marker of increased risk in patients with coronary heart disease
Clin Physiol Funct Imaging, 34 (5), 389-96
DOI 10.1111/cpf.12110, PubMed 24438358

Kjeldsen SE, Schumacher H, Neldam S, Guthrie RM (2013)
Telmisartan/Hydrochlorothiazide combination therapy for the treatment of hypertension: a pooled analysis in older and younger patients
J Clin Hypertens (Greenwich), 15 (6), 380-8
DOI 10.1111/jch.12089, PubMed 23730986

Krogseth M, Wyller TB, Engedal K, Juliebø V (2013)
Delirium is a risk factor for institutionalization and functional decline in older hip fracture patients
J Psychosom Res, 76 (1), 68-74
DOI 10.1016/j.jpsychores.2013.10.006, PubMed 24360144

Kuliczkowski W, Urbaniak J, Hallén J, Woźniak M, Poloński L, Mysiak A, Atar D, Zembala M, Serebruany V (2013)
Matrix metalloproteinases and the activity of their tissue inhibitors in patients with ST-elevation myocardial infarction treated with primary angioplasty
Kardiol Pol, 71 (5), 453-63
DOI 10.5603/KP.2013.0091, PubMed 23788085

Larsson E, Wahlstrand B, Hedblad B, Hedner T, Kjeldsen SE, Melander O, Lindahl P (2013)
Hypertension and genetic variation in endothelial-specific genes
PLoS One, 8 (4), e62035
DOI 10.1371/journal.pone.0062035, PubMed 23637959

Limalanathan S, Eritsland J, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P (2013)
Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR
PLoS One, 8 (8), e71780
DOI 10.1371/journal.pone.0071780, PubMed 23977143

Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Oliveira MM, Mairesse G, Crijns HJ, Simantirakis E, Atar D, Kirchhof P, Vardas P, Tavazzi L, Maggioni AP (2013)
A prospective survey in European Society of Cardiology member countries of atrial fibrillation management: baseline results of EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Europace, 16 (3), 308-19
DOI 10.1093/europace/eut373, PubMed 24351881

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F et al. (2013)
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Eur Heart J, 34 (28), 2159-219
DOI 10.1093/eurheartj/eht151, PubMed 23771844

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F et al. (2013)
2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension
Blood Press, 23 (1), 3-16
DOI 10.3109/08037051.2014.868629, PubMed 24359485

Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F et al. (2013)
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
J Hypertens, 31 (7), 1281-357
DOI 10.1097/, PubMed 23817082

Moltzau LR, Aronsen JM, Meier S, Nguyen CH, Hougen K, Ørstavik Ø, Sjaastad I, Christensen G, Skomedal T, Osnes JB, Levy FO, Qvigstad E (2013)
SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium
Br J Pharmacol, 170 (2), 366-79
DOI 10.1111/bph.12282, PubMed 23808942

Okin PM, Bang CN, Wachtell K, Hille DA, Kjeldsen SE, Dahlöf B, Devereux RB (2013)
Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy
Circ Arrhythm Electrophysiol, 6 (2), 243-51
DOI 10.1161/CIRCEP.112.977777, PubMed 23403268

Okin PM, Hille DA, Kjeldsen SE, Dahlöf B, Devereux RB (2013)
Persistence of left ventricular hypertrophy is associated with increased cardiovascular morbidity and mortality in hypertensive patients with lower achieved systolic pressure during antihypertensive treatment
Blood Press, 23 (2), 71-80
DOI 10.3109/08037051.2013.791414, PubMed 23721506

Okin PM, Hille DA, Wiik BP, Kjeldsen SE, Lindholm LH, Dahlöf B, Devereux RB (2013)
In-treatment HDL cholesterol levels and development of new diabetes mellitus in hypertensive patients: the LIFE Study
Diabet Med, 30 (10), 1189-97
DOI 10.1111/dme.12213, PubMed 23587029

Opstad TB, Pettersen AÅ, Arnesen H, Seljeflot I (2013)
The co-existence of the IL-18+183 A/G and MMP-9 -1562 C/T polymorphisms is associated with clinical events in coronary artery disease patients
PLoS One, 8 (9), e74498
DOI 10.1371/journal.pone.0074498, PubMed 24040261

Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GØ (2013)
IL-6 signalling in patients with acute ST-elevation myocardial infarction
Results Immunol, 4, 8-13
DOI 10.1016/j.rinim.2013.11.002, PubMed 24707455

Rohla M, Freynhofer MK, Tentzeris I, Farhan S, Wojta J, Huber K, Weiss TW (2013)
Plasma osmolality predicts clinical outcome in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Eur Heart J Acute Cardiovasc Care, 3 (1), 84-92
DOI 10.1177/2048872613516018, PubMed 24337920

Rønning B, Wyller TB, Jordhøy MS, Nesbakken A, Bakka A, Seljeflot I, Kristjansson SR (2013)
Frailty indicators and functional status in older patients after colorectal cancer surgery
J Geriatr Oncol, 5 (1), 26-32
DOI 10.1016/j.jgo.2013.08.001, PubMed 24484715

Scheiman JM, Herlitz J, Veldhuyzen van Zanten SJ, Lanas A, Agewall S, Nauclér EC, Svedberg LE, Nagy P (2013)
Esomeprazole for prevention and resolution of upper gastrointestinal symptoms in patients treated with low-dose acetylsalicylic acid for cardiovascular protection: the OBERON trial
J Cardiovasc Pharmacol, 61 (3), 250-7
DOI 10.1097/FJC.0b013e31827cb626, PubMed 23188121

Schmieder RE, Grassi G, Kjeldsen SE (2013)
Patients with treatment-resistant hypertension report increased stress and anxiety: a worldwide study
J Hypertens, 31 (3), 610-5; discussion 615
DOI 10.1097/HJH.0b013e32835d6e53, PubMed 23303395

Schmieder RE, Redon J, Grassi G, Kjeldsen SE, Mancia G, Narkiewicz K, Parati G, Ruilope L, van de Borne P, Tsioufis C, European Society of Hypertension (2013)
Updated ESH position paper on interventional therapy of resistant hypertension
EuroIntervention, 9 Suppl R, R58-66
DOI 10.4244/EIJV9SRA11, PubMed 23732157

Schwartz T, Sanner H, Gjesdal O, Flatø B, Sjaastad I (2013)
In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity
Ann Rheum Dis, 73 (10), 1805-10
DOI 10.1136/annrheumdis-2013-203279, PubMed 23881732

Shuvy M, Atar D, Gabriel Steg P, Halvorsen S, Jolly S, Yusuf S, Lotan C (2013)
Oxygen therapy in acute coronary syndrome: are the benefits worth the risk?
Eur Heart J, 34 (22), 1630-5
DOI 10.1093/eurheartj/eht110, PubMed 23554440

Skretteberg PT, Grundvold I, Kjeldsen SE, Engeseth K, Liestøl K, Erikssen G, Erikssen J, Gjesdal K, Bodegard J (2013)
Seven-year increase in exercise systolic blood pressure at moderate workload predicts long-term risk of coronary heart disease and mortality in healthy middle-aged men
Hypertension, 61 (5), 1134-40
DOI 10.1161/HYPERTENSIONAHA.111.00793, PubMed 23529164

Skretteberg PT, Grytten AN, Gjertsen K, Grundvold I, Kjeldsen SE, Erikssen J, Mellbin L, Liestøl K, Fraser DA, Erikssen G, Pedersen TR, Bodegard J (2013)
Triglycerides-diabetes association in healthy middle-aged men: modified by physical fitness? A long term follow-up of 1962 Norwegian men in the Oslo Ischemia Study
Diabetes Res Clin Pract, 101 (2), 201-9
DOI 10.1016/j.diabres.2013.06.001, PubMed 23827210

Slot KMHB, Berge E (2013)
Factor Xa Inhibitors Versus Vitamin K Antagonists for Preventing Cerebral or Systemic Embolism in Patients With Atrial Fibrillation
Stroke, 44 (12), E165-E167
DOI 10.1161/STROKEAHA.113.003453

Solheim S, Seljeflot I, Lunde K, Bratseth V, Aakhus S, Forfang K, Arnesen H (2013)
Prothrombotic markers in patients with acute myocardial infarction and left ventricular thrombus formation treated with pci and dual antiplatelet therapy
Thromb J, 11 (1), 1
DOI 10.1186/1477-9560-11-1, PubMed 23311309

Sprigg N, Selby J, Fox L, Berge E, Whynes D, Bath PM, Efficacy of Nitric Oxide in Stroke Investigators (2013)
Very low quality of life after acute stroke: data from the Efficacy of Nitric Oxide in Stroke trial
Stroke, 44 (12), 3458-62
DOI 10.1161/STROKEAHA.113.002201, PubMed 24149005

Stokstad MT, Berge HM, Gjesdal K (2013)
[Cardiac screening of young athletes]
Tidsskr Nor Laegeforen, 133 (16), 1722-5
DOI 10.4045/tidsskr.13.0016, PubMed 24005709

Strand ME, Herum KM, Rana ZA, Skrbic B, Askevold ET, Dahl CP, Vistnes M, Hasic A, Kvaløy H, Sjaastad I, Carlson CR, Tønnessen T, Gullestad L, Christensen G, Lunde IG (2013)
Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart
FEBS J, 280 (10), 2228-47
DOI 10.1111/febs.12161, PubMed 23374111

Thelle DS, Selmer R, Gjesdal K, Sakshaug S, Jugessur A, Graff-Iversen S, Tverdal A, Nystad W (2013)
Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309,540 men and women
Heart, 99 (23), 1755-60
DOI 10.1136/heartjnl-2013-303825, PubMed 23749790

Tveit A, Seljeflot I, Smith P, Arnesen H, Svendsen JH (2013)
Angiotensin II blockade, YKL-40 and maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation
Immunobiology, 218 (10), 1256-60
DOI 10.1016/j.imbio.2013.04.014, PubMed 23731775

Ulimoen SR, Enger S, Pripp AH, Abdelnoor M, Arnesen H, Gjesdal K, Tveit A (2013)
Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation
Eur Heart J, 35 (8), 517-24
DOI 10.1093/eurheartj/eht429, PubMed 24135831

van der Hoeven EJ, Schonewille WJ, Vos JA, Algra A, Audebert HJ, Berge E, Ciccone A, Mazighi M, Michel P, Muir KW, Obach V, Puetz V, Wijman CA, Zini A, Kappelle JL, BASICS Study Group (2013)
The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomised controlled trial
Trials, 14, 200
DOI 10.1186/1745-6215-14-200, PubMed 23835026

Vengen OA, Abdelnoor M, Westheim AS, Smith G, Fjeld NB (2013)
Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
J Cardiothorac Surg, 8, 142
DOI 10.1186/1749-8090-8-142, PubMed 23724788

Verheugt FW, Clemmensen P, Mehran R, Agewall S, Pocock SJ, Goldstein S, Torp-Pedersen C, Simoons ML, Borer JS, Khder YM, Burton P, Deliargyris E, McMurray JJ, Berkowitz SD, Stough WG, Zannad F (2013)
Antithrombotic outcome trials in acute coronary syndromes: seeking the optimal balance between safety and efficacy
Eur Heart J, 34 (22), 1621-9
DOI 10.1093/eurheartj/eht013, PubMed 23382466

von Lueder TG, Atar D, Krum H (2013)
Diuretic use in heart failure and outcomes
Clin Pharmacol Ther, 94 (4), 490-8
DOI 10.1038/clpt.2013.140, PubMed 23852396

von Lueder TG, Sangaralingham SJ, Wang BH, Kompa AR, Atar D, Burnett JC, Krum H (2013)
Renin-angiotensin blockade combined with natriuretic peptide system augmentation: novel therapeutic concepts to combat heart failure
Circ Heart Fail, 6 (3), 594-605
DOI 10.1161/CIRCHEARTFAILURE.112.000289, PubMed 23694773

Weiss TW, Arnesen H, Seljeflot I (2013)
Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness
Metabolism, 62 (7), 1008-13
DOI 10.1016/j.metabol.2013.01.019, PubMed 23428306

Wexels F, Haslund A, Dahl OE, Pripp AH, Gudmundsen TE, Laszlo F, Seljeflot I, Borris LC, Lassen MR (2013)
Thrombin split products (prothrombin fragment 1 + 2) in urine in patients with suspected deep vein thrombosis admitted for radiological verification
Thromb Res, 131 (6), 560-3
DOI 10.1016/j.thromres.2013.04.019, PubMed 23680105

Wisløff T, Atar D, Sønbø Kristiansen I (2013)
Cost effectiveness of drug-eluting stents as compared with bare metal stents in patients with coronary artery disease
Am J Ther, 20 (6), 596-601
DOI 10.1097/MJT.0b013e3182211a01, PubMed 21822114

Zannad F, Stough WG, Regnault V, Gheorghiade M, Deliargyris E, Gibson CM, Agewall S, Berkowitz SD, Burton P, Calvo G, Goldstein S, Verheugt FW, Koglin J, O'Connor CM (2013)
Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges
Int J Cardiol, 167 (5), 1772-82
DOI 10.1016/j.ijcard.2012.12.018, PubMed 23298559

Øyehaug L, Loose KØ, Jølle GF, Røe ÅT, Sjaastad I, Christensen G, Sejersted OM, Louch WE (2013)
Synchrony of cardiomyocyte Ca(2+) release is controlled by T-tubule organization, SR Ca(2+) content, and ryanodine receptor Ca(2+) sensitivity
Biophys J, 104 (8), 1685-97
DOI 10.1016/j.bpj.2013.03.022, PubMed 23601316

Aamodt AH, Sandset PM, Atar D, Tveit A, Russell D (2013)
[Atrial fibrillation and stroke]
Tidsskr Nor Laegeforen, 133 (14), 1453-7
DOI 10.4045/tidsskr.12.0850, PubMed 23929293